Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Magellan Health stock in Canada

Own Magellan Health shares in just a few minutes.

Magellan Health is a healthcare plans business based in the US. Magellan Health stocks (MGLN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Magellan Health employs 9,000 staff and has a trailing 12-month revenue of around $4.8 billion.

How to buy shares in Magellan Health

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MGLN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Magellan Health stock price (NASDAQ:MGLN)

Use our graph to track the performance of MGLN stocks over time.

Magellan Health shares at a glance

Information last updated 2022-01-24.
Latest market close$0.00
52-week range$82.94 - $99.36
50-day moving average $94.68
200-day moving average $94.47
Wall St. target price$95.00
PE ratio 8.4858
Dividend yield N/A (0%)
Earnings per share (TTM) $11.19

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Magellan Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Magellan Health price performance over time

Historical closes compared with the close of $0 from 2022-01-19

1 week (2022-01-17) nan%
1 month (2021-12-27) -100.00%
3 months (2021-10-24) nan%
6 months (2021-07-28) -100.00%
1 year (2021-01-28) -100.00%
2 years (2020-01-28) -100.00%
3 years (2019-01-28) 64.77
5 years (2017-01-27) 75.75

Is Magellan Health under- or over-valued?

Valuing Magellan Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Magellan Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Magellan Health's P/E ratio

Magellan Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Magellan Health shares trade at around 8x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Magellan Health's PEG ratio

Magellan Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.93. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Magellan Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Magellan Health's EBITDA

Magellan Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $86.8 million.

The EBITDA is a measure of a Magellan Health's overall financial performance and is widely used to measure a its profitability.

Magellan Health financials

Revenue TTM $4.8 billion
Operating margin TTM 0.6%
Gross profit TTM $120.8 million
Return on assets TTM 0.54%
Return on equity TTM -0.16%
Profit margin 6.26%
Book value $73.44
Market capitalisation $2.5 billion

TTM: trailing 12 months

Magellan Health share dividends

We're not expecting Magellan Health to pay a dividend over the next 12 months.

Have Magellan Health's shares ever split?

Magellan Health's shares were split on a 1:308 basis on 6 January 2004. So if you had owned 308 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Magellan Health shares – just the quantity. However, indirectly, the new 30700% higher share price could have impacted the market appetite for Magellan Health shares which in turn could have impacted Magellan Health's share price.

Magellan Health share price volatility

Over the last 12 months, Magellan Health's shares have ranged in value from as little as $82.94 up to $99.36. A popular way to gauge a stock's volatility is its "beta".

MGLN.US volatility(beta: 1.04)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Magellan Health's is 1.0353. This would suggest that Magellan Health's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Magellan Health overview

Magellan Health, Inc. , together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site